| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 1001 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 954 |
| 2 | TACROLIMUS OINTMENT 0.1% | 954 |
| 3 | PREDNISONE | 896 |
| 4 | MYCOPHENOLATE MOFETIL | 597 |
| 5 | PREDNISOLONE | 557 |
| 6 | PREDNISOLONE ORAL | 557 |
| 7 | PREDNISOLONE ORAL SOLUTION | 557 |
| 8 | METHYLPREDNISOLONE | 347 |
| 9 | METHOTREXATE SODIUM | 224 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEDIZOLID PHOSPHATE | 11 | 0.0137 |
| 1 | ATOVAQUONE | 94 | 0.0114 |
| 2 | TELMISARTAN AND AMLODIPINE | 1 | 0.0100 |
| 3 | VALGANCICLOVIR | 173 | 0.0091 |
| 4 | IMIPENEM AND CILASTATIN SODIUM | 19 | 0.0090 |
| 5 | TACROLIMUS OINTMENT 0.1% | 954 | 0.0075 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 954 | 0.0075 |
| 7 | MYCOPHENILIC ACID | 155 | 0.0073 |
| 8 | UNDECYLENIC ACID | 1 | 0.0072 |
| 9 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1765 |
| 1 | Alkylating Drug [EPC] | 241 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 213 |
| 3 | Azole Antifungal [EPC] | 189 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 176 |
| 5 | Purine Antimetabolite [EPC] | 165 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 157 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 155 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 154 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 150 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimalarial [EPC] | 94 | 0.0090 |
| 1 | Antiprotozoal [EPC] | 94 | 0.0088 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 176 | 0.0079 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 155 | 0.0073 |
| 4 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 5 | 0.0039 |
| 5 | Oxazolidinone Antibacterial [EPC] | 109 | 0.0036 |
| 6 | Selective T Cell Costimulation Blocker [EPC] | 17 | 0.0036 |
| 7 | Sulfone [EPC] | 39 | 0.0036 |
| 8 | Interferon gamma [EPC] | 5 | 0.0035 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 66 | 0.0034 |